Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Era Of Billion Dollar Pharma Settlements

Related Content

Botox Reimbursement Training Is Driving Factor In Allergan Settlement With DOJ

Sep 01 2010

Omnicare Settlement With DoJ Shows Power Of Nursing Homes In Driving Rxs

Nov 09 2009

Lilly $1.4B Zyprexa Settlement Is Biggest Ever, But Some State Claims Still Pending

Jan 15 2009

GSK’s Deal With DoJ Is Fourth In Eight Years; Exec Liability Uncertain

Nov 07 2011

Ranbaxy’s $500 Million GMP Settlement Would Be Second Most Expensive For Rx Manufacturing Violations

Jan 02 2012

AstraZeneca Hit With New Compliance Mandates In Seroquel Settlement With States

Mar 11 2011

KV Settles DoJ Complaint Over Claims For Unapproved Drugs; Two Dozen Companies Sued

Dec 06 2011

Vioxx Settlement Down, Merck Has Three More Government Probes Pending

Dec 05 2011

J&J Takes The Lead In Settling SEC/DoJ Foreign Corrupt Practices Act Probe

Apr 08 2011

Merck Serono Settlement On Rebif Kickbacks Expands, Extends Existing Integrity Agreement With OIG

May 04 2011

Novartis Inks Second Off-Label Settlement With DoJ, Paying $72.5 Million Over TOBI Marketing

May 05 2010

Rx Fraud Cases: Beat Goes On As Whistleblowers Pursue Lesser Allegations

Apr 02 2012

Abbott Avoids Compliance Requirements In Kos Off-Label Marketing Settlement

Dec 13 2010

Elan Investment In Zonegran Marketing Instead Of Clinical Trails Proves Costly In DoJ Settlement

Dec 16 2010

Legal Briefs: AstraZeneca Wins Seroquel Suit, King Settles With DoJ, Sanofi Resolves Gender Discrimination Suit

Mar 22 2010

KV Pharmaceutical To Decide Whether To Retain Generics Business After Settling Manufacturing Cover-up Charges With DoJ

Mar 08 2010

Pfizer's Record-Breaking $2.3 Bil. Settlement With U.S. Attorney Imposes New Restrictions on Corporate Behavior

Sep 07 2009

A Closer Look: Health Care Fraud Investigations In Pharma Sector Take New Twists

Mar 31 2008

Topamax "Doctor For A Day" Program Drove Off-Label Settlement

Apr 30 2010

Forest Admits To Knowingly Obstructing FDA Inspection In Guilty Pleas On Levothroid, Celexa Marketing

Sep 15 2010

DoJ Sets Its Sights On DESI Drugs: Eon Labs Settles Claims It Marketed An Ineffective Drug

Feb 23 2010

GSK’s $750 Mil. DoJ Settlement: When GMP Violations Equal Healthcare Fraud

Nov 01 2010

AstraZeneca Seroquel Settlement With DoJ Leaves Door Open To Possible Criminal Claims

Apr 27 2010

Schwarz Pharma Settles False Claims Suit For $22 Million, As DoJ Continues Focus On DESI Drugs

Apr 29 2010

Novartis Settlement Encompasses Whistleblower Claims Of Kickbacks For Diovan Prescribing

Oct 01 2010

Related Companies

Abbott

Eli Lilly and Company

Pfizer Inc.

GSK plc

Additional Topics

United States Legal Issues Regulation BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window